Trv Gp V, LLC reported 4 holdings worth US$475M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Trv Gp V, LLC reported 4 holdings worth US$475M as of Sep 30, 2026. Largest: Septerna, Inc., Rapport Therapeutics, Inc. and Maze Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 4
- Value as reported
- US$475M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Septerna, Inc. | 6.07M | US$237M | 50.0% |
| Rapport Therapeutics, Inc. | 6.28M | US$211M | 44.4% |
| Maze Therapeutics, Inc. | 951K | US$25.8M | 5.4% |
| Lisata Therapeutics, Inc. | 455K | US$655K | 0.14% |
Source
Download original · View original at SEC